Emergent Biosolutions, Inc. (EBS) Social Stream
EMERGENT BIOSOLUTIONS INC (EBS) Price Targets From Analysts
Use the tables below to see what analysts covering EMERGENT BIOSOLUTIONS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 7 | $120 | $50 | $83.666 | $3.27 | 2458.59% |
| 2021-11-10 | 7 | $120 | $50 | $80 | $3.27 | 2346.48% |
| 2022-01-18 | 6 | $75 | $50 | $62.5 | $3.27 | 1811.31% |
| 2022-02-25 | 6 | $77 | $55 | $66.4 | $3.27 | 1930.58% |
| 2022-02-28 | 6 | $77 | $40 | $61 | $3.27 | 1765.44% |
| 2022-03-09 | 6 | $77 | $40 | $60.8 | $3.27 | 1759.33% |
| 2022-04-27 | 6 | $77 | $40 | $60.6 | $3.27 | 1753.21% |
| 2022-05-02 | 6 | $77 | $30 | $56.6 | $3.27 | 1630.89% |
| 2022-05-03 | 6 | $77 | $30 | $50.2 | $3.27 | 1435.17% |
| 2022-05-04 | 6 | $77 | $30 | $48.166 | $3.27 | 1372.97% |
| 2022-05-10 | 5 | $77 | $30 | $48.166 | $3.27 | 1372.97% |
| 2022-06-06 | 5 | $65 | $30 | $44.5 | $3.27 | 1260.86% |
| 2022-08-03 | 5 | $65 | $30 | $43 | $3.27 | 1214.98% |
| 2022-09-13 | 5 | $65 | $29 | $42.833 | $3.27 | 1209.88% |
| 2022-10-26 | 5 | $65 | $29 | $42.666 | $3.27 | 1204.77% |
| 2022-11-09 | 5 | $55 | $25 | $40.333 | $3.27 | 1133.43% |
| 2022-11-11 | 5 | $55 | $23 | $38.166 | $3.27 | 1067.16% |
| 2023-03-02 | 4 | $55 | $15 | $31.2 | $3.27 | 854.13% |
| 2023-03-17 | 4 | $55 | $9 | $28.4 | $3.27 | 768.5% |
| 2023-04-17 | 4 | $38 | $9 | $21.8 | $3.27 | 566.67% |
| 2023-05-11 | 4 | $25 | $9 | $17.75 | $3.27 | 442.81% |
| 2023-05-31 | 4 | $22 | $9 | $15.25 | $3.27 | 366.36% |
| 2023-08-02 | 2 | $22 | $15 | $18.5 | $3.27 | 465.75% |
| 2023-08-10 | 2 | $22 | $11 | $16.5 | $3.27 | 404.59% |
The Trend in the Analyst Price Target
EBS's average price target has moved down $65.33 over the prior 39 months.
EBS reports an average of 119.44% for its upside potential over the past 41 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-11 | 5 | 55 | 23 | 32.80 | 15.74 | 108.39% |
| 2022-11-11 | 4 | 55 | 23 | 32.80 | 15.74 | 108.39% |
| 2023-03-02 | 4 | 55 | 15 | 31.20 | 11.81 | 164.18% |
| 2023-05-19 | 4 | 22 | 9 | 15.25 | 8.17 | 86.66% |
| 2023-05-31 | 2 | 22 | 9 | 15.25 | 8.53 | 78.78% |
EBS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 2 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
EBS's average broker recommendation rating improved by 0.2 over the prior 43 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, EMERGENT BIOSOLUTIONS INC's upside potential (average analyst target price relative to current price) is greater than 2891.54% of them.
- In terms of how EMERGENT BIOSOLUTIONS INC fares relative to stocks in the mid market cap category, note that its variance in analysts' estimates is lower than -2223.89% of that group.
- EMERGENT BIOSOLUTIONS INC's number of analysts covering the stock is higher than 697.62% of stocks in the mid market cap category.
- In the context of Pharmaceutical Products stocks, EMERGENT BIOSOLUTIONS INC's average analyst price target is greater than 1855.74% of them.
Stocks similar to EMERGENT BIOSOLUTIONS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SUPN, PBH, and ICPT.
View All Top Stocks by Price Target
What is the outlook for EBS? Use POWR Ratings for clearer insight into price direction.